Workflow
生物化工
icon
Search documents
浙江工业大学 郑裕国/柳志强 CEJ 工程化醛脱氢酶与碳通量重构助力大肠杆菌实现可持续无抗高产1,4-丁二醇合成
Core Viewpoint - The article discusses the sustainable production of 1,4-butanediol (BDO) through engineered Escherichia coli, highlighting the potential for antibiotic-free fermentation methods and the optimization of metabolic pathways to enhance yield and efficiency [2][4][20]. Summary by Sections Introduction - 1,4-butanediol (BDO) is a significant non-natural chemical widely used in biodegradable plastics, with a substantial market potential. Traditional production relies on petrochemical methods, while biotechnological approaches face challenges such as low enzyme activity and high production costs [2][4]. Research Content - The study systematically optimized the E. coli chassis by integrating multiple copies of BDO synthesis genes, knocking out byproduct pathways, and engineering key enzymes to enhance metabolic flux. The introduction of a microaerobic fermentation strategy allowed for high BDO yields without antibiotics or inducers [4][5]. Metabolic Engineering Strategies - The research involved various strategies to improve BDO production, including: - Introducing external enzymes and optimizing gene expression to enhance BDO synthesis [7][11]. - Modifying the TCA cycle and enhancing ATP levels to redirect carbon flux towards BDO production [15][18]. - Utilizing the hok/sok system to maintain plasmid stability, achieving a low plasmid loss rate of 5.5% [18][19]. Production Results - In shake flask experiments, BDO production reached 7.88 g/L, the highest reported yield under similar conditions. In a 5-liter bioreactor, BDO production achieved 34.63 g/L with a glucose yield of 0.35 g/g and a production rate of 0.48 g/L/h [20][21]. Conclusion - The study demonstrates a comprehensive metabolic engineering approach for the sustainable industrial production of BDO from glucose, showcasing the potential for antibiotic-free processes and the need for further optimization to address byproduct accumulation [20][22].
牵手巴斯夫,全球最大工厂投产!
DT新材料· 2025-07-16 14:43
Core Viewpoint - The article discusses the production and market potential of bio-based 1,4-butanediol (BDO), highlighting the shift towards sustainable chemical production methods in response to environmental concerns and regulatory pressures. Group 1: Bio-based BDO Production - Cargill and HELM AG's joint venture Qore has officially launched the production of bio-based BDO using locally grown dent corn, with a total investment of $300 million, aiming for an annual production capacity of 66,000 tons [3] - BDO is a crucial organic chemical and fine chemical raw material with extensive downstream applications across various industries, including textiles, pharmaceuticals, and biodegradable plastics [4] - The production of bio-based BDO is primarily achieved through fermentation processes, with Qore utilizing a proprietary one-step fermentation technology developed by Genomatica [8] Group 2: Industry Developments and Collaborations - LYCRA plans to use QIRA to enhance the sustainability of its fibers, potentially reducing its carbon footprint by up to 44% [5] - BASF has entered a long-term supply agreement with Qore to incorporate QIRA into its product portfolio, aiming for sustainable chemical production [5] - Several companies are investing in bio-based BDO production, including the Korean company Xinying Group, which plans to build a $1 billion facility in Vietnam, and Jinfa Technology, which has launched a 10,000-ton bio-based BDO project in Liaoning [9][10] Group 3: Market Trends and Future Outlook - The traditional BDO production methods face challenges due to high carbon emissions, necessitating the development of greener, low-carbon production processes [7] - Despite the current higher costs of bio-based BDO compared to petroleum-based BDO, its competitive advantage is expected to grow as oil prices remain high and production technologies improve [12] - The upcoming SynBioCon 2025 conference will focus on the development and industrial collaboration of key products that can replace petrochemical raw materials, indicating a strong industry shift towards sustainable practices [13]
宁玉强:生物制造产业核心领域现状和趋势研判
Core Viewpoint - The article discusses the rapid development and potential of the biomanufacturing industry, highlighting its role in the Fourth Industrial Revolution and the significant growth opportunities it presents in various sectors, particularly in China [3][4]. Industry Overview - Biomanufacturing is defined as an advanced production method centered on industrial biotechnology, utilizing biological resources and processes to produce target products at scale [5]. - The global biomanufacturing industry is projected to reach approximately $12,190 billion in 2024, with a year-on-year growth of 7.4%, and is expected to exceed $20 trillion by 2030, with a compound annual growth rate (CAGR) of 8.4% [9]. Market Dynamics - In China, the biomanufacturing industry is anticipated to reach a scale of 1.01 trillion yuan in 2024, growing by 15.4%, and is expected to surpass 2.5 trillion yuan by 2030, with a CAGR of 16.8% [9][10]. - The top three segments in China's biomanufacturing industry in 2024 will be biopharmaceuticals, biological food, and bio-chemical products, with biopharmaceuticals remaining the largest segment [10]. Technological Advancements - The industry is experiencing a shift from traditional resource reliance to technology-driven approaches, with significant improvements in biomass resource utilization and equipment efficiency [8]. - Innovations in biopharmaceuticals, such as the development of bispecific antibodies and ADC drugs, have seen an annual growth of 65% in product pipelines [8][12]. Application and Impact - In the medical field, biomanufacturing technologies like 3D printing are enabling personalized implants, achieving gross margins of 75% [9]. - In agriculture, microbial fertilizers have improved corn yields by 12% while reducing chemical fertilizer usage by 30% [9]. Future Trends - The article outlines several key trends, including the restructuring of industrial ecosystems, regional layout changes, deepening technological revolutions, product innovation iterations, and capital factor restructuring [17][18][19]. - The integration of AI and biotechnology is expected to enhance production efficiency and product quality, with significant implications for the industry [18]. Strategic Recommendations - Companies are encouraged to build a three-dimensional competitive system focusing on technology research and development, scene innovation, and ecosystem construction [20]. - Local governments should create a supportive industrial service matrix to foster the growth of the biomanufacturing sector [20].
谭天伟院士团队期待你的加入!
Group 1 - The article introduces the "Green Bio-Manufacturing" National Key Laboratory, established by Beijing University of Chemical Technology, Tsinghua University, and Dabeinong Group, focusing on producing liquid fuels and important chemicals from non-food biomass resources to support the reduction of fossil resources and CO2 emissions [1][3]. - The laboratory is led by Professor Tan Tianwei, an academician of the Chinese Academy of Engineering, who has a distinguished background in education and research, having trained over 100 graduate students [1][5]. - The research team includes a diverse group of experts, such as 1 academician, 6 distinguished young scholars, and 30 professors, with established verification bases and industrial connections [5]. Group 2 - The laboratory is recruiting several postdoctoral researchers to work on synthetic biology, enzyme catalysis, fermentation engineering, and chemical simulation, with responsibilities including laboratory management [6]. - Candidates should have a PhD in relevant fields, with a maximum of 3 years since obtaining their degree, and must demonstrate independent research capabilities and teamwork spirit [6][7]. - The compensation for postdoctoral positions follows the university's standards, with salaries ranging from 180,000 to 250,000 CNY per year, and additional benefits such as housing support for certain scholars [6]. Group 3 - The Syn BioCon 2025 conference will be held from August 20-22 in Ningbo, Zhejiang, focusing on opportunities in bio-manufacturing for the bio-chemical and new materials industries [9]. - The conference will cover five key areas: AI + bio-manufacturing, green chemistry and new materials, future food, future agriculture, and beauty raw materials, aiming to explore trends and innovations in the bio-manufacturing industry [9][12]. - Participants from various sectors, including industry leaders, experts, and government representatives, are invited to discuss the future of bio-manufacturing and promote the scaling and transfer of technological achievements [9].
利民股份: 公司关于为子公司提供担保的进展公告
Zheng Quan Zhi Xing· 2025-06-30 16:11
Summary of Key Points Group 1: Guarantee Overview - The company has agreed to provide a joint liability guarantee for its subsidiary, Hebei Weiyuan Biochemical Co., Ltd., for a total amount not exceeding RMB 680 million for the year 2025 [1] - The guarantee is effective from the date of approval at the company's 2024 annual general meeting until the relevant guarantee amount proposal is reviewed at the 2025 annual general meeting [1] Group 2: Guarantee Progress - The company has provided a maximum guarantee for all main contracts signed between Weiyuan Biochemical and Bank of Communications Co., Ltd. Hebei Branch from June 17, 2025, to June 17, 2026, with a maximum debt amount of RMB 52 million [2] Group 3: Board of Directors' Opinion - The board believes that the guarantee for Weiyuan Biochemical is necessary for the subsidiary's daily operations and long-term development, aligning with the company's overall interests and not harming the interests of the company or minority shareholders [2] Group 4: Total External Guarantees - As of now, the total external guarantees provided by the company and its subsidiaries amount to RMB 1,126.115 million, which is 40.69% of the latest audited net assets attributable to the parent company's shareholders [2] - The guarantees provided by the company's subsidiaries to each other total RMB 50.8439 million, accounting for 1.92% of the latest audited net assets attributable to the parent company's shareholders [2] - There are no overdue guarantees, litigation-related guarantees, or losses incurred due to guarantees resulting in judgments against the company [2]
贯彻全会精神·抓落实丨全省党员干部深入学习贯彻省委十一届九次全会精神 以新担当新作为推动高质量发展取得新突破
He Nan Ri Bao· 2025-06-24 23:45
Group 1 - The core viewpoint of the articles emphasizes the importance of implementing the decisions made during the 11th Provincial Committee's 9th Plenary Session of the Communist Party of China in Henan, focusing on high-quality development and innovation-driven growth [1][2][3][4] - The "Two Highs and Four Focuses" strategy is highlighted as a guiding principle for economic development, aiming to strengthen industries such as green food, intelligent manufacturing, and emerging sectors like hydrogen energy [1][2][3][4] - Local leaders express commitment to enhancing production capacity, optimizing the business environment, and ensuring food security through high-standard farmland construction [2][3] Group 2 - The articles discuss various local initiatives aimed at fostering economic growth, such as the development of new quality productivity and the integration of technology in traditional industries [1][2][3] - There is a strong emphasis on the role of party leadership in grassroots governance and community engagement, with examples of successful community service brands and smart governance platforms [4] - Educational institutions are also mentioned as key players in supporting local development by enhancing talent cultivation and research capabilities, aligning with the overall modernization goals [4]
万华化学签约!生物新材料等生物制造领域
synbio新材料· 2025-05-09 05:18
Core Viewpoint - The collaboration between Bio Island Laboratory and Wanhua Chemical aims to innovate in the field of bio-based materials, positioning both entities as leaders in the industry [1][2]. Group 1: Collaboration and Innovation - Bio Island Laboratory and Wanhua Chemical signed an agreement to establish the "Bio Island Laboratory-Wanhua Chemical Bio-Chemical Research and Manufacturing Innovation Consortium" [1]. - The partnership focuses on continuous innovation in bio-based materials and aims to lead the direction of industry development [1][2]. - The collaboration is part of a broader initiative to create a "government-industry-university-research-finance-application" ecosystem to accelerate the transformation of scientific achievements into productive forces [2]. Group 2: Industry Insights - The bio-manufacturing industry is projected to reach a value of approximately $30 trillion, making it a strategic area of competition among countries [2]. - Guangzhou's government is committed to supporting the transformation of scientific achievements and fostering innovation in the bio-economy, aiming to secure a strategic position in the future of this sector [2]. Group 3: Related Developments - The National Development and Reform Commission has included multiple projects related to bio-based materials and biofuels [5]. - Companies like Lianlong are leveraging synthetic biology to develop high-performance materials, indicating a trend towards innovation in polymer materials [5]. - A startup in synthetic biology has raised $6.7 million in seed funding to advance applications in protein fibers, showcasing the growing interest and investment in this field [5].